| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019293530 |
| P356 | DOI | 10.1016/S0893-133X(01)00345-1 |
| P698 | PubMed publication ID | 11751031 |
| P2093 | author name string | Kathryn A Cunningham | |
| Michael G Bankson | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 40-52 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors | |
| P478 | volume | 26 |
| Q45236952 | 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221. |
| Q46856527 | 5-HT(1B) receptor inhibition of alcohol-heightened aggression in mice: comparison to drinking and running |
| Q34766538 | 5-HT2C ligands: recent progress |
| Q35015786 | 5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy |
| Q39164871 | A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment |
| Q35745285 | Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function |
| Q40353383 | Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats |
| Q35990486 | Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) in rats |
| Q45342467 | Attenuation of the disruptive effects of (+/-)3,4-methylenedioxymethamphetamine and cocaine on delayed matching-to-sample performance with D1 versus D2 antagonists |
| Q44423335 | Blockade of serotonin 5-HT 1B and 5-HT 2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes |
| Q34971199 | Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model |
| Q48697149 | Caffeine alters the behavioural and body temperature responses to mephedrone without causing long-term neurotoxicity in rats. |
| Q43076563 | Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy'). |
| Q36227275 | Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats |
| Q40157269 | Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA ('Ecstasy') Substance Use Disorder |
| Q33187198 | Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats |
| Q35965775 | Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats |
| Q45968734 | Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. |
| Q31033315 | Ecstasy: are animal data consistent between species and can they translate to humans? |
| Q28483306 | Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats |
| Q34391195 | Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats |
| Q44830693 | Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA. |
| Q34804435 | Effects of prenatal protein malnutrition on the hippocampal formation |
| Q46399265 | Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat. |
| Q35576531 | Heat increases MDMA-enhanced NAcc 5-HT and body temperature, but not MDMA self-administration |
| Q24632527 | In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat |
| Q34270096 | In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. |
| Q34320172 | Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade |
| Q44407124 | Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density |
| Q35085894 | Influences of activity wheel access on the body temperature response to MDMA and methamphetamine |
| Q44618105 | Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA (‘Ecstasy’) and p-chloroamphetamine in mice |
| Q46880886 | Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects |
| Q51898000 | Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour |
| Q36800689 | Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain |
| Q34364144 | MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice |
| Q34360861 | N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). |
| Q44703093 | P-glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine |
| Q48515862 | PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice. |
| Q46587077 | Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats |
| Q35590703 | Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates |
| Q34022787 | Role of serotonin in central dopamine dysfunction. |
| Q40513141 | Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine |
| Q45921167 | Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia. |
| Q27015917 | Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder |
| Q46571097 | Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse |
| Q30398111 | Sex differences in MDMA-induced toxicity in Sprague-Dawley rats. |
| Q48405043 | Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats |
| Q51915019 | The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. |
| Q35146115 | The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). |
| Q34112933 | The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives |
Search more.